Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “IrAE”

42 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 42 results

Not applicableUnknownNCT05288569
What this trial is testing

IrAE Prediction of Anti-PD-1/L1 in Lung Cancer

Who this might be right for
Immune Checkpoint InhibitorsLung Cancer
Peking Union Medical College Hospital 120
Not applicableLooking for participantsNCT05700565
What this trial is testing

Treatment of Immune-related Adverse Events Refractory to Standard Therapy and Associated Changes in Immunophenotype

Who this might be right for
Immune-related Adverse Event
Lucie Heinzerling 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT04305145
What this trial is testing

Infliximab for Treatment of Immune Checkpoint Inhibitor Colitis

Who this might be right for
Melanoma Stage IIIMelanoma Stage IVSkin Cancer Stage III+4 more
Massachusetts General Hospital 42
Not applicableStudy completedNCT04960059
What this trial is testing

NOTION: iN-home Sampling Of cyTokines in ImmunOtherapy patieNts

Who this might be right for
CancerMetastatic MelanomaRenal Cell Carcinoma+1 more
The Christie NHS Foundation Trust 24
Not applicableStudy completedNCT06247865
What this trial is testing

BIO-CHECKPOINT 0 Biomarkers to Identify Oncology Patients on ICPI at Greater Risk of irAE

Who this might be right for
Neoplasms
Portsmouth Hospitals NHS Trust 120
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07381634
What this trial is testing

The Safety and Efficacy of Ondansetron in Reducing Immune Checkpoint Inhibitor-Related Toxicities

Who this might be right for
Hepatocellular Carcinoma (HCC)IrAE
First Affiliated Hospital of Wenzhou Medical University 134
Not applicableStudy completedNCT03948724
What this trial is testing

Impact of Therapeutic Patient Education on the Toxicity of Immune Checkpoint Inhibitors in Oncology

Who this might be right for
Therapeutic Patient EducationImmune Checkpoint InhibitorsMelanoma+4 more
Institut Cancerologie de l'Ouest 411
Testing effectiveness (Phase 2)Looking for participantsNCT06470971
What this trial is testing

Siltuximab for the Prevention of Severe Immune-Related Adverse Events During Immune Checkpoint Inhibitor Rechallenge in Patients With Advanced Cancer, CIRES Trial

Who this might be right for
Advanced Malignant Solid NeoplasmHematopoietic and Lymphatic System Neoplasm
Yuanquan Yang 40
Testing effectiveness (Phase 2)WithdrawnNCT04060407
What this trial is testing

CD24Fc With Ipilimumab and Nivolumab to Decrease irAE (CINDI)

Who this might be right for
Metastatic Melanoma
Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Testing effectiveness (Phase 2)Looking for participantsNCT06037811
What this trial is testing

Early Adalimumab Induction for Immune Checkpoint Inhibitor Associated Inflammatory Arthritis

Who this might be right for
Inflammatory ArthritisImmune-related Adverse Event
Tom Appleton 30
Testing effectiveness (Phase 2)Looking for participantsNCT05663775
What this trial is testing

Prophylactic Mesalamine to Prevent Colitis Following Treatment With Ipilimumab/Nivolumab (Ipi/Nivo)

Who this might be right for
Immune-related Adverse EventDiarrheaAdvanced Melanoma+1 more
AHS Cancer Control Alberta 20
Not applicableActive Not RecruitingNCT03409016
What this trial is testing

Biomarkers of Immune-Related Toxicity

Who this might be right for
CancerMetastatic Cancer
University of Colorado, Denver 69
Post-approval studies (Phase 4)Not Yet RecruitingNCT06785974
What this trial is testing

Statins to Prevent Immune Checkpoint Inhibitor-induced PRogression of AtherosLerosis

Who this might be right for
AtherosclerosisMelanomaImmune-related Adverse Event
Erasmus Medical Center 140
Not applicableStudy completedNCT05450367
What this trial is testing

Predictive Markers of Response and Toxicity in Patients With a Haematological Malignancy Treated With Immunotherapy.

Who this might be right for
Blood Cancer
Assistance Publique - Hôpitaux de Paris 249
Not applicableLooking for participantsNCT05813418
What this trial is testing

Identification of Predictive Biomarkers for Immune-Related Adverse Events (irAEs) in Patients Undergoing Immune CheckPoint Inhibitors (ICPI) Treatment

Who this might be right for
ImmunotherapyImmune Checkpoint InhibitorsImmune-related Adverse Event+1 more
Centre Hospitalier Universitaire, Amiens 150
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07313202
What this trial is testing

Ivarmacitinib in Advanced Solid Tumors: A Prospective, Two-Cohort, Two-Phase Exploratory Study in Patients Discontinued Due to Immune Intolerance

Who this might be right for
Patients With Advanced Solid Tumors Who Discontinued Treatment Due to irAE
Fujian Cancer Hospital 72
Not applicableEnrolling By InvitationNCT07499128
What this trial is testing

Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event

Who this might be right for
Cytokine Release SyndromeNeoplasmsLymphoma+13 more
National Cancer Institute (NCI) 136
Testing effectiveness (Phase 2)Looking for participantsNCT06860542
What this trial is testing

Inhaled Budesonide for REcurrence Prevention and Adjuvant THerapy in Checkpoint Inhibitor Pneumonitis

Who this might be right for
PneumonitisImmune-related Adverse Event
AHS Cancer Control Alberta 94
Not applicableStudy completedNCT05544292
What this trial is testing

Rheumatic IMmune-Related Adverse Events in Patients Treated With Immune Check Point Inhibitors

Who this might be right for
Immune-related Adverse Event
Diakonhjemmet Hospital 69
Not applicableLooking for participantsNCT05799898
What this trial is testing

Fast-Track Cardiovascular Assessment for Suspicion of Cardiovascular Events on Immunecheckpoint Inhibitors

Who this might be right for
CancerImmune Checkpoint InhibitorCardiovascular Complication+1 more
Institut Mutualiste Montsouris 200
Load More Results